PMID- 24272318 OWN - NLM STAT- MEDLINE DCOM- 20150105 LR - 20211021 IS - 1433-8491 (Electronic) IS - 0940-1334 (Linking) VI - 264 IP - 4 DP - 2014 Jun TI - Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. PG - 317-31 LID - 10.1007/s00406-013-0472-6 [doi] AB - To study the relationship between neurodegenerative diseases including argyrophilic grain disease (AGD) and late-onset schizophrenia and delusional disorders (LOSD; onset >/=40 years of age), we pathologically examined 23 patients with LOSD, 71 age-matched normal controls, and 22 psychiatric disease controls (11 depression, six personality disorder, two bipolar disorders, and three neurotic disorders cases). In all LOSD cases (compared to age-matched normal controls), the frequencies of Lewy body disease (LBD), AGD, and corticobasal degeneration (CBD) were 26.1 % (11.3 %), 21.7 % (8.5 %), and 4.3 % (0.0 %), respectively. There was no case of pure Alzheimer's disease (AD). The total frequency of LBD, AGD, and CBD was significantly higher in LOSD cases than in normal controls. Argyrophilic grains were significantly more severe in LOSD than in controls, but were almost completely restricted to the limbic system and adjacent temporal cortex. In LOSD patients whose onset occurred at >/=65 years of age (versus age-matched normal controls), the frequencies of LBD and AGD were 36.4 % (19.4 %) and 36.4 % (8.3 %), respectively, and AGD was significantly more frequent in LOSD patients than in normal controls. In LOSD patients whose onset occurred at <65 years of age, the frequencies of LBD, AGD, and CBD were 16.7, 8.3, and 8.3 %, comparable to those of age-matched normal controls (10.2, 5.1, and 0.0 %). In all psychiatric cases, delusion was significantly more frequent in AGD cases than in cases bearing minimal AD pathology alone. Given these findings, LOSD patients may have heterogeneous pathological backgrounds, and AGD may be associated with the occurrence of LOSD especially after 65 years of age. FAU - Nagao, Shigeto AU - Nagao S AD - Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. FAU - Yokota, Osamu AU - Yokota O FAU - Ikeda, Chikako AU - Ikeda C FAU - Takeda, Naoya AU - Takeda N FAU - Ishizu, Hideki AU - Ishizu H FAU - Kuroda, Shigetoshi AU - Kuroda S FAU - Sudo, Koichiro AU - Sudo K FAU - Terada, Seishi AU - Terada S FAU - Murayama, Shigeo AU - Murayama S FAU - Uchitomi, Yosuke AU - Uchitomi Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131123 PL - Germany TA - Eur Arch Psychiatry Clin Neurosci JT - European archives of psychiatry and clinical neuroscience JID - 9103030 RN - 0 (DNA-Binding Proteins) RN - 0 (alpha-Synuclein) RN - 0 (tau Proteins) SB - IM MH - Adult MH - Age of Onset MH - Aged MH - Aged, 80 and over MH - Brain/metabolism/*pathology MH - Case-Control Studies MH - DNA-Binding Proteins/metabolism MH - Female MH - Humans MH - Intermediate Filaments/metabolism MH - Male MH - Middle Aged MH - Neurodegenerative Diseases/*etiology/*pathology MH - Psychotic Disorders/complications/*pathology MH - Schizophrenia/*complications/*pathology MH - Statistics, Nonparametric MH - alpha-Synuclein/metabolism MH - tau Proteins/metabolism EDAT- 2013/11/26 06:00 MHDA- 2015/01/06 06:00 CRDT- 2013/11/26 06:00 PHST- 2013/06/12 00:00 [received] PHST- 2013/11/05 00:00 [accepted] PHST- 2013/11/26 06:00 [entrez] PHST- 2013/11/26 06:00 [pubmed] PHST- 2015/01/06 06:00 [medline] AID - 10.1007/s00406-013-0472-6 [doi] PST - ppublish SO - Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):317-31. doi: 10.1007/s00406-013-0472-6. Epub 2013 Nov 23.